Xiao-Xing Wang Selected Research

Leukemia

1/2011

The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Xing Wang Research Topics

Disease

10	Neoplasms (Cancer) 04/2013 - 08/2009
5	Breast Neoplasms (Breast Cancer) 02/2012 - 01/2010
2	Cystic Fibrosis (Mucoviscidosis) 08/2017 - 06/2015
2	Hypertrophy 04/2013 - 10/2010
2	Lung Neoplasms (Lung Cancer) 04/2013 - 08/2011
2	Neoplasm Metastasis (Metastasis) 02/2012 - 01/2010
2	Fibrosis (Cirrhosis) 09/2011 - 10/2010
2	Inflammation (Inflammations) 09/2011 - 10/2010
1	Acute Kidney Injury (Acute Renal Failure) 12/2021
1	Necrotizing Enterocolitis 04/2021
1	Substance-Related Disorders (Drug Abuse) 04/2016
1	Melanoma (Melanoma, Malignant) 02/2012
1	Experimental Melanoma 02/2012
1	Residual Neoplasm 01/2012
1	Lung Diseases (Lung Disease) 09/2011
1	Pneumonia (Pneumonitis) 09/2011
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2011
1	Starvation 09/2011
1	Autoimmune Diseases (Autoimmune Disease) 09/2011
1	Hypersensitivity (Allergy) 04/2011
1	Brain Neoplasms (Brain Tumor) 01/2011
1	Leukemia 01/2011
1	Cardiomegaly (Heart Hypertrophy) 10/2010
1	Hypertension (High Blood Pressure) 10/2010
1	Myopia 06/2008
1	Postoperative Pain 06/2008

Drug/Important Bio-Agent (IBA)

9	Liposomes (Liposome)IBA 04/2013 - 01/2010
5	Pharmaceutical PreparationsIBA 04/2016 - 01/2011
4	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2012 - 01/2010
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 08/2017 - 06/2015
2	Epirubicin (Ellence)FDA LinkGeneric 04/2013 - 01/2011
2	Caspase 9IBA 02/2012 - 08/2011
2	Cytochromes c (Cytochrome c)IBA 02/2012 - 08/2011
2	CytokinesIBA 09/2011 - 08/2009
2	Cytotoxins (Cytolysins)IBA 02/2011 - 08/2009
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 04/2021
1	GlucuronidesIBA 08/2017
1	ProdrugsIBA 06/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2015
1	Antineoplastic Agents (Antineoplastics)IBA 04/2013
1	lonidamineIBA 04/2013
1	Topotecan (Hycamtin)FDA LinkGeneric 02/2012
1	Quinacrine (Mepacrine)IBA 01/2012
1	3-methylamphetamineIBA 09/2011
1	Silicon Dioxide (Silica)FDA LinkGeneric 09/2011
1	Interleukin-17 (Interleukin 17)IBA 09/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2011
1	CollagenIBA 09/2011
1	Glycoproteins (Glycoprotein)IBA 09/2011
1	Ethanolamine (Colamine)IBA 08/2011
1	Dequalinium (Dequalinium Chloride)IBA 08/2011
1	ResveratrolIBA 08/2011
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2011
1	cremophor ELIBA 04/2011
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 02/2011
1	Amlodipine (Norvasc)FDA LinkGeneric 02/2011
1	Transferrin (beta 2 Transferrin)IBA 01/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2010
1	Toll-Like Receptor 4IBA 10/2010
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2010
1	p38 Mitogen-Activated Protein KinasesIBA 10/2010
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2010
1	Tamoxifen FDA LinkGeneric 01/2010
1	Gemcitabine FDA Link 08/2009
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2009
1	Chaperonin 60IBA 08/2009
1	ChemokinesIBA 08/2009

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 02/2012 - 01/2010
4	Therapeutics 04/2013 - 01/2011
2	Oral Administration 06/2015 - 04/2011
2	Heterologous Transplantation (Xenotransplantation) 01/2012 - 02/2011
1	Lung Transplantation 12/2021
1	Intravenous Administration 04/2011
1	Laser In Situ Keratomileusis (LASIK) 06/2008